MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
PPBT Purple Biotech
- 4.510
- -0.080-1.74%
Close Jan 3 16:00 ET
- 4.688
- +0.178+3.94%
Post 19:39 ET
11.65MMarket Cap-0.61P/E (TTM)
4.711High4.410Low50.28KVolume4.520Open4.590Pre Close226.42KTurnover2.20%Turnover RatioLossP/E (Static)2.58MShares20.60052wk High0.40P/B10.31MFloat Cap2.00052wk Low--Dividend TTM2.29MShs Float1390.000Historical High--Div YieldTTM6.55%Amplitude2.000Historical Low4.502Avg Price1Lot Size
Purple Biotech News
Purple Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(8.69%),Steven Boyd(8.69%)
Purple Biotech | D: Filing D
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Purple Biotech | D: Filing D
Purple Biotech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Purple Biotech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Purple Biotech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Purple Biotech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Purple Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Purple Biotech | D: Filing D
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(4.99%),Armistice Capital Master Fund Ltd.(4.99%), etc.
Purple Biotech | D: Filing D
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(4.99%),Armistice Capital Master Fund Ltd.(4.99%), etc.
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals
Purple Biotech | D: Filing D
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(4.99%),Armistice Capital Master Fund Ltd.(4.99%), etc.
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Purple Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ran Nussbaum(13.4%),Tomer Kariv(13.4%), etc.
Purple Biotech | D: Filing D
Purple Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(4.99%),Ryan M. Lane(4.99%), etc.
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.